COLUMBIA, Md. (AP) — Osiris Therapeutics Inc. (OSIR) on Wednesday reported profit of $4.2 million in its third quarter.

The Columbia, Maryland-based company said it had net income of 12 cents per share. Earnings, adjusted to account for discontinued operations, came to 11 cents per share.

The developer of treatments using adult human mesenchymal stem cells posted revenue of $36.5 million in the period.

Osiris shares have risen 67 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $10, a rise of 71 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on OSIR at

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.